Re: ZE Slides Up

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZE Slides Up

in response to

ZE Slides Up

Topcoin

posted on Jan 08, 2019 04:36PM

Thanks Topcoin. The new presentation seems to be focused much more on enhancing existing cancer drugs than previous presentations. Interestingly the TNBC drug that they are starting this new combo trial with is not on the list of drugs that were synergistic with ZEN-3694.